Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve the Unaudited Financial ....
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care has informed the exchanges that its Board of Directors will meet on Tuesday, February 3, 2026, via video conferencing. The Board will consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2025 (Q3 FY26). The Board will also consider declaring a 2nd Interim Dividend for the financial year 2025-26. The trading window for dealing in the company's equity shares remains closed from January 1, 2026, to February 5, 2026, as is standard practice before results announcements.
This is a routine advance intimation with no direct price impact. Investors should watch the Q3 results on Feb 3 for actual revenue, profit, and margin trends. The 2nd interim dividend declaration (if approved) would be a positive signal reflecting strong cash flows and shareholder-friendly capital allocation.